KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Amgen (AMGN) Interest Expenses (2016 - 2026)

Amgen has reported Interest Expenses over the past 18 years, most recently at $657.0 million for Q1 2026.

  • For Q1 2026, Interest Expenses fell 9.13% year-over-year to $657.0 million; the TTM value through Mar 2026 reached $2.7 billion, down 11.95%, while the annual FY2025 figure was $2.8 billion, 12.68% down from the prior year.
  • Interest Expenses for Q1 2026 was $657.0 million at Amgen, up from $653.0 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $824.0 million in Q1 2024 and troughed at $295.0 million in Q1 2022.
  • A 5-year average of $638.1 million and a median of $694.0 million in 2025 define the central range for Interest Expenses.
  • Biggest five-year swings in Interest Expenses: skyrocketed 129.27% in 2023 and later decreased 14.11% in 2025.
  • Year by year, Interest Expenses stood at $415.0 million in 2022, then soared by 97.83% to $821.0 million in 2023, then decreased by 9.01% to $747.0 million in 2024, then decreased by 12.58% to $653.0 million in 2025, then increased by 0.61% to $657.0 million in 2026.
  • Business Quant data shows Interest Expenses for AMGN at $657.0 million in Q1 2026, $653.0 million in Q4 2025, and $685.0 million in Q3 2025.